Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Disorders of Hemostasis01:24

Disorders of Hemostasis

1.9K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.9K
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

245
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
245
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

11.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.7K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

254
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
254
X-linked Traits01:19

X-linked Traits

58.1K
In most mammalian species, females have two X sex chromosomes and males have an X and Y. As a result, mutations on the X chromosome in females may be masked by the presence of a normal allele on the second X. In contrast, a mutation on the X chromosome in males more often causes observable biological defects, as there is no normal X to compensate. Trait variations arising from mutations on the X chromosome are called “X-linked”.
58.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanoreceptor plexin D1 regulates lymphatic valve morphogenesis and lymphedema pathogenesis.

The Journal of clinical investigation·2026
Same author

Predicted versus observed outcomes in the ALT-FLOW early feasibility study.

ESC heart failure·2026
Same author

Comparative analysis of randomized versus real-world populations in heart failure: DIAMOND trial vs CARE-HK registry.

ESC heart failure·2026
Same author

Balancing Clinical and Ethical Considerations Related to Placebo Use in Trials of Incretin-Based Therapies in Heart Failure.

Journal of the American College of Cardiology·2026
Same author

Exclusion of CLIC5 as a Candidate Gene and Identification of NEFM as a Possible Novel Gene Correlated With Autosomal Recessive Pure Cerebellar Ataxia in a Highly Consanguineous Family.

Molecular genetics & genomic medicine·2026
Same author

The effect of vericiguat on sudden cardiac death: insights from the VICTOR trial.

European journal of heart failure·2026
Same journal

An unusual cause of obstructing laryngeal edema: Forestier's disease. <b>Case report and literature review</b>.

Acta bio-medica : Atenei Parmensis·2026
Same journal

IgA Vasculitis following AstraZeneca/Oxford COVID-19, case report.

Acta bio-medica : Atenei Parmensis·2023
Same journal

Acute paraplegia in a patient with eosinophilic granulomatosis and polyangiitis with 20 years of evolution: case report.

Acta bio-medica : Atenei Parmensis·2023
Same journal

SARS-CoV-2 infection in meat and poultry workers after the "first wave" (Summer 2020): a cross-sectional study on knowledge, attitudes, practices (KAP) of Italian occupational physicians.

Acta bio-medica : Atenei Parmensis·2023
Same journal

The impact of pediatric congenital heart disease on primary teeth structure: a histological study.

Acta bio-medica : Atenei Parmensis·2023
Same journal

Predictors of neuropathic dysesthetic pain occurrence and chronification in multiple sclerosis (2-year prospective study).

Acta bio-medica : Atenei Parmensis·2023
See all related articles

Related Experiment Video

Updated: Jan 6, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.3K

Hereditary thrombophilia.

Astrit Dautaj1, Geraldo Krasi, Vilma Bushati

  • 1MAGI Balkans, Tirana, Albania. genetica.clinica@assomagi.org.

Acta Bio-Medica : Atenei Parmensis
|October 3, 2019
PubMed
Summary
This summary is machine-generated.

Thrombophilia increases blood clot risk, stemming from inherited or acquired causes. Genetic testing aids in diagnosing inherited thrombophilia, like Factor V Leiden, and assessing familial risk.

More Related Videos

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
07:00

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

Published on: April 1, 2019

10.3K
Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

967

Related Experiment Videos

Last Updated: Jan 6, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.3K
A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
07:00

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

Published on: April 1, 2019

10.3K
Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

967

Area of Science:

  • Hematology
  • Genetics
  • Medical Diagnostics

Background:

  • Thrombophilia encompasses disorders characterized by an elevated tendency for blood clot formation.
  • These conditions can arise from inherited or acquired factors.
  • Thrombophilia is a significant risk factor for deep venous thrombosis and venous thromboembolism.

Purpose of the Study:

  • To provide an overview of thrombophilia, including its causes and implications.
  • To highlight the prevalence and significance of inherited thrombophilia, such as Factor V Leiden.
  • To underscore the utility of genetic testing in managing thrombophilia.

Main Methods:

  • Review of existing literature on thrombophilia.
  • Discussion of genetic inheritance patterns (autosomal dominant, recessive, X-linked).
  • Emphasis on the role of genetic testing in diagnosis and risk assessment.

Main Results:

  • Factor V Leiden thrombophilia is the most prevalent inherited form.
  • Prothrombin-related thrombophilia is the second most common genetic form, affecting 1.7-3% of European and US populations.
  • Genetic testing is crucial for confirming diagnoses, evaluating recurrence risks, and identifying asymptomatic family members with known mutations.

Conclusions:

  • Thrombophilia presents a considerable risk for thromboembolic events.
  • Understanding the genetic basis and inheritance patterns is key to managing thrombophilia.
  • Genetic testing offers valuable diagnostic and prognostic information for individuals and families affected by thrombophilia.